Yi Wan Lim

4PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 24, 2025
Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer.

Felix Blanc-Durand, Etienne Rouleau, Patricia Pautier

|Jul 24, 2025
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.

Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu

|Jul 08, 2021
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.

Manavi Sachdeva, Natalie Y L Ngoi, Diana Lim

Pageof 1